- Translational Core Laboratories
- Vector Production
- Cellular Processing
- Schedule Instrument
- Contact Us
Research Cellular Products
Human cell products for your research
The Cell Processing Core offers a variety of human hematopoietic cells or other products to investigators for their research programs. The Core can provide specific cell populations such as total nucleated cells, low density mononuclear cells or CD34+ cells from bone marrow, umbilical cord blood, peripheral blood or G-CSF mobilized peripheral blood through a Normal Donor Repository. Other enriched cell populations may be available via special request. The Core can also provide unprocessed samples, plasma, serum, buccal swabs or urine.
Investigators may submit a request for products using the Normal Donor Request Form (under the request forms section to the left). The laboratory will either provide cryopreserved products available in our biorepository or arrange for collection and preparation of samples through The Clinical Translational Research Center for samples as required. A current IRB approval should be provided with the request form, although investigators receiving samples without any identifying information may be able to receive samples without an IRB approval.
Costs for services are billed to the respective account or charged to the PO or Credit Card through the Cincinnati Children's Research Administration Service Center. Services provided to CCHMC investigators who are part of the Center of Excellence in Molecular Hematology are subsidized. Services provided to investigators at outside institutions, fees include standard overhead charges.
Other Blood Products including unprocessed samples and plasma or serum are also available.
Contact us for more information or complete a Request form to initiate your order.
1. Bui KC, Senadheera D, Wang X, Hendrickson B, Friedlich P, Lutzko C. Isolation of progenitors from the peripheral blood of patients with acute respiratory or cardiac failure who required ECMO support. American Journal of Respiratory and Critical Care Medicine 181: 226-237, 2010
2. Lutzko C, Kruth S, Abrams-Ogg, ACG, Lau K, Li L, Clark BR, Ruedy C, Nanji S, Foster R, Kohn D, Shull RM, Dube ID. Genetically corrected autologous stem cells engraft, but host immune responses and vector silencing limit their utility in canine a-L-iduronidase deficiency. Blood 93:1895-1905, 1999
3. Omori F, Lutzko C, Abrams-Ogg ACG, Lau K, Gartley C, Dobson H, Nanji S, Ruedy C, Reis M, Robinson J, Pinkerton P, Stewart AK, Kruth S, Dube ID. Adoptive transfer of genetically modified human hematopoietic stem cells into preimmune canine fetuses. Experimental Hematology 27:242-249, 1999